Participation rates for organized colorectal cancer screening programmes: An international comparison

Journal of Medical Screening

Volumn 22, Issue 3, 2015, Pages 119-126

  Klabunde, Carrie ^a   Blom, Johannes ^b   Bulliard, Jean Luc ^c   Garcia, Montse ^d   Hagoel, Lea ^e   Mai, Verna ^f   Patnick, Julietta ^g   Rozjabek, Heather ^h   Senore, Carlo ⁱ   Törnberg, Sven ^j  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^e CARMEL MEDICAL CENTER   (Israel)

^f Canadian Partnership Against Cancer   (Canada)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h DREXEL UNIVERSITY   (United States)

ⁱ CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^j KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

Colorectal; FOBT; Neoplasm; Organized programmes; Participation; Population; Screening; Uptake

Indexed keywords

GUAIAC;

AGED; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; FECES; FEMALE; HUMAN; INFORMATION PROCESSING; INTERNATIONAL COOPERATION; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT ATTITUDE; PATIENT PARTICIPATION; PATIENT SELECTION; PROCEDURES; QUESTIONNAIRE; SEX DIFFERENCE;

AGED; COLORECTAL NEOPLASMS; DATA COLLECTION; EARLY DETECTION OF CANCER; FECES; FEMALE; GUAIAC; HUMANS; INTERNATIONAL COOPERATION; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; PATIENT SELECTION; SEX FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84960426517     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141315584694     Document Type: Article

References (22)

1. Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989 Jun;59(6): 954-8. PubMed PMID: 2736233. PubMed Central PMCID: 2246734.
2. Weller DP, Patnick J, McIntosh HM, Dietrich AJ. Uptake in cancer screening programmes. Lancet Oncol 2009 Jul;10(7): 693-9. PubMed PMID: 19573798.
3. von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, et al. European Colorectal Cancer Screening Guidelines Working G. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 2013;45(1): 51-9. PubMed PMID: 23212726.
4. Bulliard JL, Garcia M, Blom J, Senore C, Mai V, Klabunde C. Sorting out measures and definitions of screening participation to improve comparability: The example of colorectal cancer. Eur J Cancer 2014;50(2): 434-46.
5. Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS, et al.. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 2008 Mar 15;122(6): 1357-67. PubMed PMID: 18033685.
6. Dowling EC, Klabunde C, Patnick J, Ballard-Barbash R International Cancer Screening N. Breast and cervical cancer screening programme implementation in 16 countries. J Med Screen 2010;17(3): 139-46. PubMed PMID: 20956724.
7. Federici A, Marinacci C, Mangia M, Borgia P, Giorgi Rossi P, Guasticchi G. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A clusterrandomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy. Cancer Detect Prev 2006;30(4): 347-53. PubMed PMID: 16965874.
8. von Euler-Chelpin M, Brasso K, Lynge E. Determinants of participation in colorectal cancer screening with faecal occult blood testing. Journal of public health 2010 Sep;32(3): 395-405. PubMed PMID: 20015868.
9. von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol 2011 Jun;40(3): 712-8. PubMed PMID: 21330344.
10. Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, et al.. Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network. Int J Cancer 2012 Jun 15;130(12): 2961-73. PubMed PMID: 21792895.
11. Jacobsen KK, von Euler-Chelpin M. Performance indicators for participation in organized mammography screening. Journal of public health 2012 Jun;34(2): 272-8. PubMed PMID: 22233570.
12. Giordano L, von Karsa L, Tomatis M, Majek O, de Wolf C, Lancucki L, et al.. Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen 2012;19(Suppl 1): 72-82. PubMed PMID: 22972813.
13. Malila N, Palva T, Malminiemi O, Paimela H, Anttila A, Hakulinen T, et al.. Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland. J Med Screen 2011;18(1): 18-23. PubMed PMID: 21536812.
14. Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, von Wagner C. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut 2014 May;7PubMed PMID: 24812001.
15. Blom J, Kilpelainen S, Hultcrantz R, Tornberg S. Five-year experience of organized colorectal cancer screening in a Swedish population - increased compliance with age, female gender, and subsequent screening round. J Med Screen 2014 Sep;21(3): 144-50. PubMed PMID: 25070434.
16. Malila N, Oivanen T, Hakama M. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme. Z Gastroenterol 2008 Apr;46(Suppl 1): S25-8. PubMed PMID: 18368636. Epub 2008/06/26. eng.
17. Rees CJ, Bevan R. The National Health Service Bowel Cancer Screening Program: the early years. Expert review of gastroenterology & hepatology 2013 Jul;7(5): 421-37. PubMed PMID: 23899282.
18. Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S. Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev 2005;29(3): 221-6. PubMed PMID: 15896925.
19. Rabeneck L, Rumble RB, Thompson F, Mills M, Oleschuk C, Whibley A, et al.. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol 2012 Mar;26(3): 131-47. PubMed PMID: 22408764. PubMed Central PMCID: 3299236.
20. Le Breton J, Journy N, Attali C, Le Corvoisier P, Brixi Z, Bastuji-Garin S, et al.. Improving participation in colorectal cancer screening: targets for action. Prev Med 2012 Nov;55(5): 488-92. PubMed PMID: 22926013.
21. Ore L, Hagoel L, Lavi I, Rennert G. Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance. Eur J Cancer Prev 2001 Jun;10(3): 251-6. PubMed PMID: 11432712.
22. Camilloni L, Ferroni E, Cendales BJ, Pezzarossi A, Furnari G, Borgia P, et al.. Methods to increase participation in organised screening programs: a systematic review. BMC Public Health 2013;13:464. PubMed PMID: 23663511. PubMed Central PMCID: 3686655.